Seniors Are Experiencing Record-High RSV Cases

The video discusses the rise in RSV cases, particularly among the elderly, due to weakened immune systems and reduced precautions post-pandemic. It highlights the health risks posed by RSV, flu, and COVID-19, and the ongoing development of RSV vaccines by companies like Pfizer and Moderna. The discussion emphasizes the vulnerability of older adults, including those in nursing facilities, and the importance of protecting both the young and the elderly.

What is a primary reason for the increase in RSV cases among the elderly?

• Improved diagnostic techniques

• Higher birth rates

• Reduced social distancing and mask-wearing

• Increased travel among seniors

Which of the following is NOT a physiological change in older adults that increases RSV risk?

• Stronger immune system

• Osteoporosis

• Smaller chest cavity

• Weakened lungs

What is the average number of older adults hospitalized with RSV each year according to the CDC?

• 50,000

• 80,000

• 150,000

• 120,000

Which companies are involved in developing RSV vaccines for seniors?

• Bayer, Abbott, Eli Lilly

• Pfizer, GSK, Moderna

• Johnson & Johnson, AstraZeneca, Novartis

• Sanofi, Merck, Roche

Why is it important to consider both young children and older adults in RSV prevention efforts?

• They both have strong immune systems

• They are both at high risk for severe RSV complications

• They both have similar dietary needs

• They both live in similar environments